Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to learn about the genetic background for the development of optic disc drusen. The main question is: • Can one or more candidate genes be found? Participants will have a blood sample taken and answer a questionnaire.


Clinical Trial Description

The study is an international collaboration between University of Utah, University of Sydney, University of Valladolid, and University of Copenhagen. Patients with Optic disc drusen from 15 known optic disc drusen-families from different countries (USA, Australia, Spain and Denmark) are participating in this study. Blood samples are drawn from each patient and their affected and unaffected family members, and DNA will be extracted. The investigators will do an Optical coherence tomography-scan (according to ODDS Consortium guidelines), and the participant will be asked to fill out the Visual Function Questionnaire (VFQ-25) including four additional questions about optic disc drusen. The etiology of optic disc drusen will be analyzed with a Whole Exome Sequencing (WES), with the use of Next Generation Sequencing (NGS). Prior to WES, all participants will receive genetic counseling by a consultant to ensure awareness of possible secondary genetic findings. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05736237
Study type Observational
Source Copenhagen University Hospital at Herlev
Contact alvilda H steensberg
Phone 4528257051
Email alvilda.hemmingsen.steensberg.01@regionh.dk
Status Recruiting
Phase
Start date May 1, 2023
Completion date May 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03957642 - Systematic Imaging Examination in ODD
Recruiting NCT05305079 - NA-AION Risk Factors: New Perspectives